维持性血液透析患者中无全身巨细胞病毒再激活的证据。
Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients.
机构信息
Kuratorium für Dialyse und Nierentransplantation Nierenzentrum, Renal Unit, Delitzscher Strasse 141, 04129 Leipzig, Germany.
出版信息
Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1557-60. doi: 10.1007/s10096-011-1260-8. Epub 2011 Apr 26.
PMID:21516515
Abstract
The risk of cytomegalovirus (CMV) reactivation among hemodialysis (HD) patients is unknown. In 52 HD patients from a single center, CMV serology and quantitative PCR were performed. The detection limit of PCR was 20 copies/ml. Here, PCR ruled out CMV viremia, despite CMV-IgM seropositivity in 15.4% patients.
摘要
血液透析（HD）患者的巨细胞病毒（CMV）再激活风险尚不清楚。在来自单个中心的 52 名 HD 患者中，进行了 CMV 血清学和定量 PCR 检测。PCR 的检测限为 20 拷贝/ml。在此，尽管有 15.4%的患者 CMV-IgM 血清阳性，但 PCR 排除了 CMV 病毒血症。
Zotero 插件